Shares of Medidata Solutions Inc. (NASDAQ:MDSO) saw unusually-high trading volume on Friday . Approximately 284,743 shares traded hands during trading, a decline of 8% from the previous session’s volume of 310,414 shares.The stock last traded at $48.03 and had previously closed at $47.03.

MDSO has been the topic of a number of research reports. Zacks Investment Research raised shares of Medidata Solutions from a “hold” rating to a “buy” rating and set a $51.00 target price on the stock in a report on Friday, April 29th. Citigroup Inc. boosted their target price on shares of Medidata Solutions from $40.00 to $55.00 and gave the stock a “buy” rating in a report on Friday, April 22nd. Needham & Company LLC reissued a “buy” rating and set a $57.00 target price (up from $45.00) on shares of Medidata Solutions in a report on Friday, April 22nd. Topeka Capital Markets reissued a “buy” rating and set a $51.00 target price (up from $44.00) on shares of Medidata Solutions in a report on Friday, April 22nd. Finally, KeyCorp reissued a “buy” rating on shares of Medidata Solutions in a report on Thursday. One analyst has rated the stock with a sell rating, two have issued a hold rating and nine have assigned a buy rating to the company. Medidata Solutions presently has a consensus rating of “Buy” and an average price target of $51.40.

The firm has a market capitalization of $2.66 billion and a price-to-earnings ratio of 147.76. The firm has a 50-day moving average price of $45.71 and a 200 day moving average price of $41.90.

Medidata Solutions (NASDAQ:MDSO) last posted its quarterly earnings results on Thursday, April 21st. The company reported $0.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.18 by $0.07. The firm had revenue of $104.20 million for the quarter, compared to the consensus estimate of $103.22 million. Medidata Solutions’s quarterly revenue was up 12.7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.17 EPS. On average, equities research analysts forecast that Medidata Solutions Inc. will post $1.01 earnings per share for the current year.

In related news, CEO Tarek Sherif sold 7,500 shares of the firm’s stock in a transaction dated Tuesday, July 5th. The stock was sold at an average price of $46.35, for a total transaction of $347,625.00. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Vice Chairman Steven Isaac Hirschfeld sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, April 27th. The shares were sold at an average price of $45.09, for a total value of $450,900.00. Following the sale, the insider now directly owns 125,867 shares in the company, valued at approximately $5,675,343.03. The disclosure for this sale can be found here.

Other large investors recently modified their holdings of the company. American Century Companies Inc. increased its stake in shares of Medidata Solutions by 214.5% in the fourth quarter. American Century Companies Inc. now owns 276,914 shares of the company’s stock worth $13,649,000 after buying an additional 188,871 shares during the last quarter. Brown Advisory Inc. increased its stake in shares of Medidata Solutions by 28.1% in the fourth quarter. Brown Advisory Inc. now owns 662,156 shares of the company’s stock worth $32,638,000 after buying an additional 145,439 shares during the last quarter. Sawtooth Asset Management Inc. increased its stake in shares of Medidata Solutions by 7,730.8% in the fourth quarter. Sawtooth Asset Management Inc. now owns 20,360 shares of the company’s stock worth $1,004,000 after buying an additional 20,100 shares during the last quarter. Century Capital Management LLC increased its stake in shares of Medidata Solutions by 18.8% in the fourth quarter. Century Capital Management LLC now owns 126,397 shares of the company’s stock worth $6,230,000 after buying an additional 20,027 shares during the last quarter. Finally, Bank of Montreal Can increased its stake in shares of Medidata Solutions by 96.6% in the fourth quarter. Bank of Montreal Can now owns 33,760 shares of the company’s stock worth $1,664,000 after buying an additional 16,587 shares during the last quarter.

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Medidata Clinical Cloud provides a platform of technology and data analytics solutions designed to manage activities across clinical development.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.